Although a few studies have been reported to date, this approach has led to the identification of a pan-cancer gene set [16], a classifier for chronic lymphocytic leukaemia [17] and synthetic lethal genes in BRCA2-associated ovarian tumours [18]. This evidence concerns the gene BRCA2 and ovarian neoplasm.